How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Year: 2016
Type: article
Study design: Observational Study
Abstract: Background Assessments of stroke and bleeding risks are essential to selecting oral anticoagulation in patients with atrial fibrillation (AF). We aimed to assess outcomes according to physician assessed risk, with comparison to empirical risk scores. Methods This was a prospective, observational study of 9,715 outpatients with AF enrolled in ORBIT-AF, a US national registry. Stroke and bleeding risks were quantified by physician assignment, CHADS 2 and CHA 2 DS 2 -VASc stroke scores, and ATRIA and HAS-BLED bleeding scores. Outcomes were stroke or systemic embolism and major bleeding during a median follow-up of 28 months. Results Physician-assigned risk was associated with thromboembolic events: low risk (0.71 per 100 patient-years [95% CI 0.56-0.91], n = 3,991), intermediate risk (0.98 [95% CI 0.79-1.20], n = 4,148), and high risk (1.84 [95% CI 1.43-2.37], n = 1,576, P < .0001), and major bleeding: low (3.43 [95% CI 3.07-3.82], n = 4,250), intermediate (4.55 [95% CI 4.03-5.15], n = 2,702), and high (5.76 [95% CI 4.42-7.50], n = 468; P < .0001). Discrimination of stroke risk was similar with CHADS 2 ( c = 0.59, 95% CI 0.57-0.61) vs physician assessment ( c = 0.58, 95% CI 0.55-0.62). Among patients on oral anticoagulation, bleeding risk discrimination was higher with ATRIA ( c = 0.63, 95% CI 0.61-0.65) and HAS-BLED ( c = 0.60, 95% CI 0.59-0.62) than with physician assessment (0.55, 95% CI 0.53-0.57). Physician-assessed risk categories did not add significantly to empirical risk scores, in Cox models for outcomes ( P adjusted > .05 for all physician assessments vs P adjusted < .05 for empirical scores). Conclusion Physician-assigned risk showed a graded relationship with outcomes, and both physician-based and empirical scores yielded only moderate discrimination. Although empirical scores provided valuable risk stratification information (with or without physician judgment), physician assessment added little to existing scores. These data support the use of empirical scores for stroke and bleeding risk stratification, and the need for novel approaches to risk stratification in this population.
Source: American Heart Journal
Institutions: Duke University, Duke Medical Center, Duke Clinical Research Institute, University of California, Los Angeles, Lenox Hill Hospital, New York University, Lankenau Institute for Medical Research, Harvard University, Massachusetts General Hospital, Mayo Clinic, Stanford Medicine, Stanford University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,070
Funders: American Heart Association, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Medtronic, Boehringer Ingelheim, Boston Scientific Corporation, Bayer HealthCare, Daiichi-Sankyo, Genentech, Johnson and Johnson, Forest Laboratories, St. Jude Medical, Baxter Healthcare Corporation, Janssen Pharmaceuticals
OpenAlex ID: W2514727205
